<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><issn pub-type="epub">3033-8344</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2025-6-1-27-37</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-554</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь клубочковых и канальцевых повреждений с клиническим течением, морфо-функциональными параметрами сердца и показателями гемодинамики у больных ишемической болезнью сердца, постинфарктным кардиосклерозом и артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Relationship between glomerular and tubularile kidney injuries and clinical course, morpho-functional parameters of the heart and hemodynamic indicators in patients with coronary heart disease, postinfarction cardiosclerosis and arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Битарова</surname><given-names>З. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bitarova</surname><given-names>Z. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зарина Вячеславовна Битарова, старший лаборант</p><p>Республика Северная Осетия — Алания; Владикавказ</p></bio><bio xml:lang="en"><p>Zarina V. Bitarova, senior laboratory assistant</p><p>Republic of North Ossetia-Alania; Vladikavkaz </p></bio><email xlink:type="simple">Bit.zarina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ремизов</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Remizov</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олег Валерьевич Ремизов, руководитель кафедры</p><p>кафедра ЮНЕСКО «Образование в области здоровья для устойчивости развития»</p><p>Республика Северная Осетия — Алания; Владикавказ</p></bio><bio xml:lang="en"><p>Oleg V. Remizov, Head of the Department</p><p>UNESCO Department “Health Education for Sustainable Development”</p><p>Republic of North Ossetia-Alania; Vladikavkaz </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Астахова</surname><given-names>З. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Astakhova</surname><given-names>Z. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Замира Татарбековна Астахова, заведующая кафедры</p><p>кафедра Внутренних болезней № 4</p><p>Республика Северная Осетия — Алания; Владикавказ</p></bio><bio xml:lang="en"><p>Zamira T. Astakhova, Head of the Department</p><p>Department of Internal Medicine No. 4</p><p>Republic of North Ossetia-Alania; Vladikavkaz </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВО «Северо-Осетинская Государственная Медицинская Академия» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>North Ossetian State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2025</year></pub-date><volume>6</volume><issue>1</issue><fpage>27</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Битарова З.В., Ремизов О.В., Астахова З.Т., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Битарова З.В., Ремизов О.В., Астахова З.Т.</copyright-holder><copyright-holder xml:lang="en">Bitarova Z.V., Remizov O.V., Astakhova Z.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/554">https://www.therapeutic-j.ru/jour/article/view/554</self-uri><abstract><sec><title>   Цель</title><p>   Цель: изучение особенностей кардио-ренальных взаимоотношений у больных ишемической болезнью сердца (ИБС), перенёсших инфаркт миокарда, в сочетании с хронической болезнью почек (ХБП).</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы: в исследование были включены 110 пациентов ИБС, перенёсших острый инфаркт миокарда (ОИМ) в сочетании с артериальной гипертензией 1–2 степени, которые также имели ХБП 1–3Б стадий. Клиническое исследование включало уточнение функционального класса хронической сердечной недостаточности (ХСН) с помощью теста 6-минутной ходьбы (ТШХ), оценку тяжести ХСН по шкале ШОКС, электрокардиографию (ЭКГ), эхокардиографию (ЭХОКГ), суточное мониторирование артериального давления (СМАД), холтеровское мониторирование ЭКГ. Функциональное состояние почек оценивалось по уровню скорости клубочковой фильтрации (СКФ) (формула CKD-EPI), отношению альбумина к креатинину в суточной моче (АУ), а также по уровню N-ацетил-β-D-глюкозаминидазы (NAG) в моче.</p></sec><sec><title>   Результаты</title><p>   Результаты: превышение уровня референсных значений NAG в моче продемонстрировало тесную связь с повреждением эпителия проксимальных канальцев. Уровни NAG и АУ тесно связаны. При анализе значений ТШХ было установлено, что по мере снижения значения ТШХ происходило повышение уровня АУ. Повышение балла по шкале ШОКС ассоциировалось со снижением СКФ. Значимой корреляционной связи данного параметра с АУ и NAG в моче выявлено не было. По мере дилатации левых отделов сердца, а также снижения систолической функции и прогрессирования гипертрофии миокарда происходило статистически значимое снижение СКФ. Значения NAG в моче и АУ были выше в подгруппе пациентов с концентрической гипертрофией. В ходе анализа взаимосвязей показателей СМАД и параметров, отражающих повреждение почечной ткани, было отмечено нарастание среднесуточного систолического АД (САД) по мере прироста уровня NAG в моче и снижения СКФ. Повышение уровня NAG в моче также ассоциируется с усилением вариабельности САД, ростом индекса времени гипертензии и скорости утреннего подъёма АД. Изменения значений СКФ и АУ имеют меньшее число связей с параметрами СМАД. При анализе результатов холтеровского мониторирования ЭКГ было установлено, что по мере снижения СКФ растет вероятность выявления случаев ишемии миокарда (СИМ), а также продолжительность всех эпизодов ишемии миокарда.</p></sec><sec><title>   Выводы</title><p>   Выводы: канальцевые повреждения в виде повышения уровня NAG в моче, клубочковые повреждения в виде АУ и снижение фильтрационной способности почек (снижение СКФ) при ХБП ассоциируются с процессами ремоделирования миокарда у больных с ИБС, ПИКС и АГ в равной мере, однако высокая вариабельность АГ, патологические суточные профили АГ в большей степени ассоциируются с наличием канальцевых повреждений, а возникновение эпизодов ишемии миокарда и продолжительность безболевой ишемии — с наличием клубочковых и канальцевых повреждений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Objective</title><p>   Objective: to study the characteristics of cardiorenal relationships in patients with coronary heart disease (CHD) who have suffered a myocardial infarction in combination with CKD.</p></sec><sec><title>   Materilas and methods</title><p>   Materilas and methods: the study included 110 patients with coronary heart disease who had suffered acute myocardial infarction (AMI) in combination with grade 1–2 hypertension, who also had CKD stages 1-3. The clinical study included clarification of the functional class of CHF using a 6-minute walk test (TSH), assessment of the severity of CHF on the SHOKS scale, electrocardiography (ECG), echocardiography (ECHOCG), daily blood pressure monitoring (SMAD), Holter ECG monitoring. The functional state of the kidneys was assessed by the level of glomerular filtration rate (GFR) (formula CKD-EPI), the ratio of albumin to creatinine in daily urine (AU), as well as by the level of N-acetyl-β-D-glucosaminidase (NAG) in urine.</p></sec><sec><title>   Results</title><p>   Results: exceeding the level of reference NAG values in urine demonstrated a close association with damage to the epithelium of the proximal tubules. In the studied group, the number of patients with a NAG level of more than 3.16 ng/ml was 96 patients (87.3%). It was shown that the levels of NAG and AU are closely related (r = 0.86, p = 0.001). When analyzing the values of TSH, it was found that as the value of TSH decreased, the level of AU increased (r = 0.34, p &lt; 0.05). It was shown that an increase in the SHOCK score was associated with a decrease in GFR (r = -0.44, p &lt; 0.05). There was no significant correlation between this parameter and AU and NAG in urine. As the left heart dilates, as well as systolic function decreases and myocardial hypertrophy progresses, there is a statistically significant decrease in GFR. It was shown that the values of NAG in urine and AU were higher in a subgroup of patients with concentric hypertrophy. During the analysis of the interrelationships of SMAD indicators and parameters reflecting damage to renal tissue, an increase in the average daily SAD was noted with an increase in the level of NAG in urine and a decrease in GFR. An increase in the level of NAG in urine is also associated with an increase in the variability of SAD, an increase in the index of hypertension time and the rate of morning blood pressure rise. Changes in the values of GFR and AU have fewer connections with the parameters of the SMAD. When analyzing the results of Holter ECG monitoring, it was found that as GFR decreases, the probability of detecting cases of myocardial ischemia (SIM) increases, as well as the duration of all episodes of myocardial ischemia. An increase in the concentration of NAG in urine is associated with an increase in the likelihood of SIM, as well as the duration of episodes of pain-free myocardial ischemia (BBIM).</p></sec><sec><title>   Conclusions</title><p>   Conclusions: tubular lesions in the form of an increase in the level of NAG in urine, glomerular lesions in the form of AU and a decrease in the filtration capacity of the kidneys (decrease in GFR) in CKD are associated with the processes of myocardial remodeling in patients with coronary heart disease, PIC and hypertension equally, however, high variability of hypertension, pathological daily profiles of hypertension are more associated with the presence of tubular lesions At the same time , the occurrence of episodes of myocardial ischemia and the duration of pain–free ischemia are associated with the presence of glomerular and tubular lesions.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>N-ацетил-β-D-глюкозаминидаза</kwd><kwd>альбуминурия</kwd><kwd>ишемическая болезнь сердца</kwd></kwd-group><kwd-group xml:lang="en"><kwd>N-acetyl-β-D-glucosaminidase</kwd><kwd>albuminuria</kwd><kwd>coronary heart disease</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study had no sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Khoshakhlagh AH, Mohammadzadeh M, Gruszecka-Kosowska A, Oikonomou E. Burden of cardiovascular disease attributed to air pollution: a systematic review. Global Health. 2024;20(1):37. DOI: 10.1186/s12992-024-01040-0</mixed-citation><mixed-citation xml:lang="en">Khoshakhlagh AH, Mohammadzadeh M, Gruszecka-Kosowska A, Oikonomou E. Burden of cardiovascular disease attributed to air pollution: a systematic review. Global Health. 2024;20(1):37. DOI: 10.1186/s12992-024-01040-0</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Qu C, Liao S, Zhang J, Cao H, Zhang H, Zhang N, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. Eur Heart J Qual Care Clin Outcomes. 2024;10(2):143-153. DOI: 10.1093/ehjqcco/qcad033</mixed-citation><mixed-citation xml:lang="en">Qu C, Liao S, Zhang J, Cao H, Zhang H, Zhang N, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. Eur Heart J Qual Care Clin Outcomes. 2024;10(2):143-153. DOI: 10.1093/ehjqcco/qcad033</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А. Резервы снижения смертности от сердечно-сосудистых заболеваний. Терапевтический архив. 2023;95(12):1052-1055. DOI: 10.26442/00403660.2023.12.202500</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A. Ways for reducing mortality from cardiovascular diseases : A review. Terapevticheskii arkhiv. 2023;95(12):1052-1055. (In Russ.) DOI: 10.26442/00403660.2023.12.202500</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Драпкина О.М. Современное содержание и совершенствование стратегии высокого сердечно-сосудистого риска в снижении смертности от сердечно-сосудистых заболеваний. Терапевтический архив. 2021;93(1):4-6. DOI: 10.26442/00403660.2021.01.200543</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A., Drapkina O.M. Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases. Terapevticheskii arkhiv. 2021;93(1):4-6. DOI: 10.26442/00403660.2021.01.200543</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pedamallu H, Zmora R, Perak AM, Allen NB. Life Course Cardiovascular Health: Risk Factors, Outcomes, and Interventions. Circ Res. 2023;132(12):1570-1583. DOI: 10.1161/CIRCRESAHA.123.321998</mixed-citation><mixed-citation xml:lang="en">Pedamallu H, Zmora R, Perak AM, Allen NB. Life Course Cardiovascular Health: Risk Factors, Outcomes, and Interventions. Circ Res. 2023;132(12):1570-1583. DOI: 10.1161/CIRCRESAHA.123.321998</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huiban N, Gehant M, Brocq FX, Collange F, Mayet A, Monteil M. Global Cardiovascular Risk and Associated Factors in 2792 French Military and Civilian Aircrew. Aerosp Med Hum Perform. 2024;95(5):233-244. DOI: 10.3357/AMHP.6415.2024</mixed-citation><mixed-citation xml:lang="en">Huiban N, Gehant M, Brocq FX, Collange F, Mayet A, Monteil M. Global Cardiovascular Risk and Associated Factors in 2792 French Military and Civilian Aircrew. Aerosp Med Hum Perform. 2024;95(5):233-244. DOI: 10.3357/AMHP.6415.2024</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Вишнева Е.М., Сагадеева О.А., Вишнева К.А. Проблема коморбидности пациентов с хронической болезнью почек и сердечно-сосудистыми заболеваниями. Medicus. 2022;3(45):24-32. eLIBRARY ID: 48467118 EDN: TELOAW</mixed-citation><mixed-citation xml:lang="en">Vishneva E.M., Sagadeyeva O.A., Vishneva K.A. The problem of comorbidity in patients with chronic kidney disease and cardiovascular diseases. Medicus. 2022;3(45):24-32. (In Russ.) eLIBRARY ID: 48467118 EDN: TELOAW</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. DOI: 10.1016/S0140-6736(20)30045-3</mixed-citation><mixed-citation xml:lang="en">GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. DOI: 10.1016/S0140-6736(20)30045-3</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chaitman BR, Cyr DD, Alexander KP, Pracoń R, Bainey KR, Mathew A, et al. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circ Cardiovasc Interv. 2022;15(8):e012103. DOI: 10.1161/CIRCINTERVENTIONS.122.012103</mixed-citation><mixed-citation xml:lang="en">Chaitman BR, Cyr DD, Alexander KP, Pracoń R, Bainey KR, Mathew A, et al. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circ Cardiovasc Interv. 2022;15(8):e012103. DOI: 10.1161/CIRCINTERVENTIONS.122.012103</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kampmann JD, Heaf JG, Mogensen CB, Petersen SR, Wolff DL, Mickley H, et al. Rate and Risk Factors of Acute Myocardial Infarction after Debut of Chronic Kidney Disease-Results from the KidDiCo. J Cardiovasc Dev Dis. 2022;9(11):387. DOI: 10.3390/jcdd9110387</mixed-citation><mixed-citation xml:lang="en">Kampmann JD, Heaf JG, Mogensen CB, Petersen SR, Wolff DL, Mickley H, et al. Rate and Risk Factors of Acute Myocardial Infarction after Debut of Chronic Kidney Disease-Results from the KidDiCo. J Cardiovasc Dev Dis. 2022;9(11):387. DOI: 10.3390/jcdd9110387</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е.В., Беленков Ю.Н., Бойцов С.А., Виллевальде С.В., Галявич А.С., Глезер М.Г., и др. Результаты промежуточного анализа проспективного наблюдательного многоцентрового регистрового исследования пациентов с хронической сердечной недостаточностью в Российской Федерации “ПРИОРИТЕТ-ХСН”: исходные характеристики и лечение первых включенных пациентов. Российский кардиологический журнал. 2023;28(10):5593. DOI: 10.15829/1560-4071-2023-5593</mixed-citation><mixed-citation xml:lang="en">Shlyakhto E.V., Belenkov Yu.N., Boytsov S.A., Villevalde S.V., Galyavich A.S., Glezer N.G., et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation “PRIORITET-CHF”: initial characteristics and treatment of the first included patients. Russian Journal of Cardiology. 2023;28(10):5593. (In Russ.) DOI: 10.15829/1560-4071-2023-5593</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yandrapalli S, Christy J, Malik A, Wats K, Harikrishnan P, Aronow W, et al. Impact of Acute and Chronic Kidney Disease on Heart Failure Hospitalizations After Acute Myocardial Infarction. Am J Cardiol. 2022;165:1-11. DOI: 10.1016/j.amjcard.2021.10.041</mixed-citation><mixed-citation xml:lang="en">Yandrapalli S, Christy J, Malik A, Wats K, Harikrishnan P, Aronow W, et al. Impact of Acute and Chronic Kidney Disease on Heart Failure Hospitalizations After Acute Myocardial Infarction. Am J Cardiol. 2022;165:1-11. DOI: 10.1016/j.amjcard.2021.10.041</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gilbert C, Cherney DZ, Parker AB, Mak S, Floras JS, Al-Hesayen A, et al. Hemodynamic and neurochemical determinates of renal function in chronic heart failure. Am J Physiol Regul Integr Comp Physiol. 2016;310(2):R167-75. DOI: 10.1152/ajpregu.00190.2015</mixed-citation><mixed-citation xml:lang="en">Gilbert C, Cherney DZ, Parker AB, Mak S, Floras JS, Al-Hesayen A, et al. Hemodynamic and neurochemical determinates of renal function in chronic heart failure. Am J Physiol Regul Integr Comp Physiol. 2016;310(2):R167-75. DOI: 10.1152/ajpregu.00190.2015</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng H, Liu X, Sharma NM, Li Y, Pliquett RU, Patel KP. Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure. Hypertension. 2016;67(1):197-205. DOI: 10.1161/HYPERTENSIONAHA.115.05838</mixed-citation><mixed-citation xml:lang="en">Zheng H, Liu X, Sharma NM, Li Y, Pliquett RU, Patel KP. Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure. Hypertension. 2016;67(1):197-205. DOI: 10.1161/HYPERTENSIONAHA.115.05838</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ouwerkerk W, Belo Pereira JP, Maasland T, Emmens JE, Figarska SM, et al. Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. J Am Coll Cardiol. 2023;82(20):1921-1931. DOI: 10.1016/j.jacc.2023.08.053</mixed-citation><mixed-citation xml:lang="en">Ouwerkerk W, Belo Pereira JP, Maasland T, Emmens JE, Figarska SM, et al. Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. J Am Coll Cardiol. 2023;82(20):1921-1931. DOI: 10.1016/j.jacc.2023.08.053</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shi K, Yuan S, Huang Y, Li Z, Wang C, Liu H, et al. Clinic-pathological characteristics of rare tubulointerstitial diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(10):1365-1374. (In English, Chinese). DOI: 10.11817/j.issn.1672-7347.2022.220127</mixed-citation><mixed-citation xml:lang="en">Shi K, Yuan S, Huang Y, Li Z, Wang C, Liu H, et al. Clinic-pathological characteristics of rare tubulointerstitial diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(10):1365-1374. (In English, Chinese). DOI: 10.11817/j.issn.1672-7347.2022.220127</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wetmore JB, Broce M, Malas A, Almehmi A. Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease. Nephron Clin Pract. 2012;122(1-2):9-16. DOI: 10.1159/000347143</mixed-citation><mixed-citation xml:lang="en">Wetmore JB, Broce M, Malas A, Almehmi A. Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease. Nephron Clin Pract. 2012;122(1-2):9-16. DOI: 10.1159/000347143</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. 2020;382(17):1608-1618. DOI: 10.1056/NEJMoa1915925</mixed-citation><mixed-citation xml:lang="en">Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. 2020;382(17):1608-1618. DOI: 10.1056/NEJMoa1915925</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
